[Detection and clinical significance of PML protein expression of acute promyelocytic leukemia cells].
Objective To study the expression patterns of promyelocytic leukemia (PML) protein at different stages of acute promyelocytic leukemia (APL) and investigate the effects that the arsenical, all-trans retinoic acid (ATRA) and chemotherapeutic drugs on PML protein expression patterns. Methods The bone marrow cells of 42 APL patients, NB4 cells and MR2 cells were collected and treated separately with 1 μmol/L arsenic trioxide (As2O3), 1 μmol/L tetra-arsenic tetra-sulfide (As4S4), 1 μmol/L ATRA, 10 mg/L cytosine arabinoside, and 1 mg/L homoharringtonine. The changes of fluorescent signals before and after the treatment were detected by indirect immunofluorescence technique. Results The 87.5% of initial onset APL cases showed small fluorescent signals (fluorescent signals in the nucleus look like a starry sky, more than 30 fluorescent light dots per cell); 91.67% of complete remission APL cases manifested large fluorescent signals (fluorescent signals in the nucleus are larger, fewer than 30 fluorescent light dots per cell); and 83.33% of relapse APL cases presented small fluorescent signals. Compared with control group without medication, the PML protein expression of APL cells in initial onset cases had larger fluorescent signals in the ATRA group, As2O3 group and As4S4 group, whereas there were no significant changes in the arabinoside cytosine group and the homoharringtonine group. In addition, ATRA transformed the PML protein expression of NB4 cells from small fluorescent signals into large ones, but did not change small fluorescent signals of the PML protein expression in MR2 cells. Also, As2O3 and As4S4 turned the PML protein expression of NB4 and MR2 cells from small fluorescent signals into large ones. Conclusion Detection of PML protein expression patterns of APL cells has practical application values for evaluating the prognosis of APL and making a rational choice of drugs.